Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Virus
100%
Human Coronavirus 229E
100%
Coronavirus
100%
Human Cells
75%
Coxsackievirus
50%
Effective Treatment
50%
8-oxoguanine
50%
Escherichia Coli
25%
Effects on Growth
25%
Wild Mice
25%
Cell Survival
25%
Induced Cell Death
25%
Klebsiella Pneumoniae (K. pneumoniae)
25%
Colon Tissue
25%
Infectious Diseases
25%
DNA Damage Markers
25%
In Vivo Model
25%
Cell Viability
25%
Enterococcus Faecalis
25%
HeLa Cells
25%
HeLa
25%
Pseudomonas Aeruginosa (P. aeruginosa)
25%
Specific Conditions
25%
Multidrug-resistant Pathogens
25%
Candida Albicans (C. albicans)
25%
Oxidative DNA Damage
25%
Proteus Mirabilis
25%
Staphylococcus Epidermidis (S. epidermidis)
25%
Dermatological Diseases
25%
Streptococcus Pyogenes (S. pyogenes)
25%
Phototherapy
25%
FDA-approved Drugs
25%
Safe Treatment
25%
Clostridioides Difficile
25%
Effects on Humans
25%
Novel Pathogen
25%
Safe Therapy
25%
Viscera
25%
Tracheal Epithelial Cells
25%
Coronavirus Spike Protein
25%
Mitochondrial Antiviral Signaling Protein
25%
Dysplastic Changes
25%
Exposure Protocol
25%
Protein Reduction
25%
Histologic Changes
25%
Pharmacology, Toxicology and Pharmaceutical Science
Coronavirinae
100%
Virus
100%
Bacterium
100%
Infectious Agent
50%
Enterovirus
33%
Deoxyguanosine
33%
Diseases
33%
Clinical Study
16%
Escherichia coli
16%
Wild Type Mouse
16%
Antiinfective Agent
16%
Cell Viability
16%
Pseudomonas aeruginosa
16%
Klebsiella pneumoniae
16%
Proteus mirabilis
16%
Candida Albicans
16%
Staphylococcus Epidermidis
16%
Streptococcus pyogenes
16%
Antivirus Agent
16%
Enterococcus faecalis
16%
Spike Protein
16%